vTv Therapeutics (VTVT) Reports In-Line Q3 EPS

vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• The LGL Group (LGL) Misses Q2 EPS by 8c
• INVO Fertility (IVF) Tops Q2 EPS by 105c